G2/M checkpoint abrogation through WEE1 inhibition was originally conceived as a strategy to selectively sensitize cancer cells to DNA damaging agents, given that most human cancers rely on the G2/M checkpoint to detect and repair damaged DNA [35]. The gene discussed is WEE1; the disease is cancer.